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Neurodegenerative disorderMacroautophagy maintains cellular homeostasis through targeting cytoplasmic contents and organelles into
autophagosomes for degradation. This process begins with the assembly of protein complexes on isolation
membrane to initiate the formation of autophagosome, followed by its nucleation, elongation andmaturation.
Fusion of autophagosomes with lysosomes then leads to degradation of the cargo. In the past decade,
signiﬁcant advances have been made on the identiﬁcation of molecular players that are implicated in various
stages of macroautophagy. Post-translational modiﬁcations of macroautophagy regulators have also been
demonstrated to be critical for the selective targeting of cytoplasmic contents into autophagosomes. In
addition, recent demonstration of distinct macroautophagy regulators has led to the identiﬁcation of different
subtypes of macroautophagy. Since deregulation of macroautophagy is implicated in diseases including
neurodegenerative disorders, cancers and inﬂammatory disorders, understanding themolecular machinery of
macroautophagy is crucial for elucidating the mechanisms by which macroautophagy is deregulated in these
diseases, thereby revealing new potential therapeutic targets and strategies. Here we summarize current
knowledge on the regulation of mammalian macroautophagy machineries and their disease-associated
deregulation.+852 2358 2765.
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Autophagy is regarded as a “self-digestion” process, which degrades
a cell's own cytoplasmic content through lysosomes, for the mainte-
nance of cellular homeostasis [1]. There are at least three types of
autophagy, including chaperone-mediated autophagy (CMA), micro-
autophagy and macroautophagy. They differ in terms of their
mechanism for directing the cytoplasmic content to the lysosomes,
where the engulfed content is degraded by lysosomal proteases into
macromolecules and are released back into the cytoplasm [2,3]. In CMA,
recognition of a speciﬁc consensus sequence on the targeted proteins by
a lysosomal chaperone directs the proteins into the lysosomes;whereas
in microautophagy, invagination leads to the direct engulfment of
cytoplasmic content by lysosome [3]. In macroautophagy, the cytoplas-
mic content is enveloped into a double-membraned vesicle called
autophagosome, through non-speciﬁc encircling of the bulk cytoplasm
or a selective process for targeted proteins, organelles, protein
aggregates and intracellular pathogens. The autophagosome then
fuses with lysosome to form an autolysosome to dispose of its content.
Precise regulation of macroautophagy is required to facilitate selective
engulfment and degradation when needed, in addition to preventing
undesired removal of cytoplasmic contents.Macroautophagy at its optimal level ensures cell homeostasis, while
its deregulation compromises cell survival [4–6]. Macroautophagy
deregulation has been demonstrated in many diseases such as
neurodegenerative disorders, cancers and inﬂammatory disorders
[3,7,8]. Interestingly, the macroautophagy pathway is deregulated via
distinct mechanisms in each disease. In neurodegenerative disorders,
impaired macroautophagic engulfment of cytosolic content and
mitochondria by autophagosomes are respectively observed in models
of Huntington's disease [9] and Parkinson's disease [10–13], whereas
autophagosome degradation is defective in Alzheimer's disease models
[14]. In inﬂammatory disorder like cystic ﬁbrosis, the machinery for
autophagosome nucleation is mislocalized, which in turn inhibits
macroautophagy [15]. Understanding the molecular control of macro-
autophagy is therefore imperative for dissecting the contribution of
macroautophagy deregulation in such diverse diseases. In this review,
we focus our discussion on the molecular regulation of mammalian
macroautophagy, and discuss how its deregulation is linked to various
diseases.
2. Molecular machinery of macroautophagy and its regulation
During the last decade, research has focused on how mammalian
macroautophagy is initiated and regulated in the cell [2,16]. Since the
macroautophagymachineries in organisms such as yeast, Caenorhabditis
elegans and Drosophila are highly conserved with those in mammals
[17–20], researchers have performed molecular and genetic screens in
these organisms to identify macroautophagy regulators, leading to the
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[21,22]. Macroautophagy involves a battery of molecular players to
initiate autophagosome formation, as well as the nucleation, elongation,
maturation, and degradation of autophagosomes. Macroautophagy
regulators are also modiﬁed post-translationally through ubiquitination,
phosphorylation and acetylation, which facilitate the delivery of
cytoplasmic contents into autophagosomes and provide an additional
level of control over macroautophagy. Furthermore, distinct molecular
machineries have been identiﬁed for selective targeting of certain
cytoplasmic contents into autophagosomes, as well as to mediate
subtypes of macroautophagy, further highlighting the complexity of
macroautophagy regulation in the cell.
2.1. Initiation of autophagosome formation
The origin of autophagosome, as the starting point of macroauto-
phagy, has been characterized as a small crescent-shaped structure called
isolation membrane or phagophore. Various intracellular membranes
have been suggested as the source of isolation membrane, including the
endoplasmic reticulum [23], golgi apparatus [24], mitochondria [25], as
well as the plasma membrane [26]. However, the mechanisms
underlying the recruitment of these membranes for autophagosome
formation remain unclear.
Initiation of macroautophagy involves the assembly of ULK protein
complex comprising ULK1, Atg13, FIP200 and Atg101 at the isolation
membranes, where this complex works with other autophagy-related
gene (Atg) proteins to initiate autophagosome formation [27] (Fig. 1).
The assembly of ULK complex is facilitated by a Ras-like small G protein
RalB and theexocyst complex [28], and its activation requiresdissociation
from the negative regulator mTOR complex 1 (mTORC1) [29] during
cellular stress such as starvation. Alternatively, macroautophagy can also
be inducedviamTOR-independentmechanisms, such as through altering
the transcription of macroautophagy genes or reducing the cellular level
of inositol 1,4,5-trisphosphate (IP3) [30,31]. For example, macroauto-
phagy is induced when IP3 production is reduced by treatment with IP3
receptor antagonists [32], pharmacological inhibition of inositol mono-
phosphatase activity or inositol synthesis [33], as well as by lowering
cyclic adenosine monophosphate (cAMP) level [30]. Interestingly, the
reduced IP3 level further decreases intracytosolic calcium ion concentra-
tion and calpain activity to lower the cAMP level, resulting in a feedback
loop for stimulating macroautophagy [30,31]. It will be interesting to
further elucidate the downstream signaling mechanism by which IP3
inhibits macroautophagy.
Atg5 and Atg12 are also key macroautophagy regulators present
on the isolation membranes [34]. Interaction of Atg5 with Atg16L1 at
the isolation membranes facilitates autophagosome formation, as
revealed by the observation that forced localization of Atg16L1 to the
plasma membrane promotes on-site autophagosome formation
[35,36]. Proteins such as phosphoinositide 3-phosphatase Jumpy
and WIPI-1 are also localized to the isolation membranes [37], and
further studies will elucidate how these proteins are implicated in the
initiation of autophagosome formation.
2.2. Autophagosome nucleation and elongation
Autophagosome formation proceeds with nucleation and elongation
of the isolationmembranes to generate vesicular structures [2,38] (Fig. 1).
Nucleation of isolation membranes requires the formation of a large
protein complex, known as Beclin 1/Class III phosphatidylinositol-3-
kinase (PI3K) complex, coordinatedby the interactionsof several proteins
including Beclin 1, UV irradiation resistance-associated tumor suppressor
gene (UVRAG), Atg14, B-cell leukemia/lymphoma-2 (Bcl-2), p150,
ambra1, endophilin B1, and PI3K Vacuolar protein sorting 34 (Vps34),
which then activates PI3K to produce phosphatidylinositol-3-phosphate
[2,31]. Beclin 1/PI3K complex formation and PI3K activity are inhibited
when Beclin 1 is bound to Bcl-2 [39], but are stimulated upon UVRAGrecruitment to the complex [40]. Ambra1 also directly binds Beclin 1 to
regulate Beclin 1/PI3K complex formation [41]. Interestingly, Atg14 and
UVRAG are located in the Beclin 1-PI3K complex in a mutually exclusive
manner [42] and Atg14 competes with UVRAG for Beclin 1 to promote
autophagosome formation [43]. Theseﬁndings suggest a coordinated role
of speciﬁc components within the Beclin 1/P13K complex to drive
nucleation of isolationmembranes.Notably, endophilinB1, also knownas
Bax-interacting factor 1 (Bif-1) [44] or SH3GLB1 [45], is hitherto the only
N-terminal Bin-Amphiphysin-Rvs (N-BAR) domain-containing protein
identiﬁed in this Beclin 1/PI3K complex, and is believed to generate
membrane curvature during vesicle nucleation [46]. The function of
endophilin B1 in macroautophagy regulation requires both its N-BAR
domain and Src-homology 3 domain,with the latter shown tomediate its
interaction with UVRAG to recruit Beclin 1 and facilitate PI3K activation
[47]. Endophilin B1 was also reported to have a role in coordinating the
intracellular trafﬁcking of another macroautophagy-related membrane
protein Atg9 [48]. Additional proteins such as PTEN-induced putative
kinase 1 (PINK1) [49], death-associated protein kinase (DAPK) [50], IP3
receptor [32] andhighmobility groupbox1 [51] have also been identiﬁed
as Beclin 1-binding protein and marcoautophagy regulator. How they
work with other partners in the Beclin 1/PI3K complex to direct
membrane nucleation are to be further examined.
Following the nucleation step, other Atg proteins are recruited to
themembrane of the pre-autophagosomes to promote elongation and
expansion, and eventually the completion of autophagosome forma-
tion [2,38] (Fig. 1). During the elongation and expansion steps, Atg7
and Atg10 facilitate the formation of a covalently-linked Atg5–Atg12
complex [52], which also interacts with Atg16L1 [35]. Together with
Atg3, Atg4 and Atg7, the Atg5–Atg12–Atg16L1 complex mediates the
conjugation of phosphatidylethanolamine (PE) to the microtubule-
associated protein 1 light chain 3 (LC3)-I to form LC3-II, leading to the
translocation of LC3 from cytoplasm to the membrane of the pre-
autophagosomes [34–36,53]. Once autophagosome formation is
completed, the Atg proteins are released back to the cytoplasm by a
yet uncharacterized mechanism.
2.3. Autophagosome maturation and degradation
Subsequent to the elongation step, autophagosomes are fused with
lysosomes for degradation of their contents, a process known as
autophagosome maturation [38,54,55]. Autophagosomes fuse with
several types of vesicles from the endosomal/lysosomal pathways
including late endosomes and lysosomes [54]. Consistently, autophago-
some maturation and degradation require the action of late endosome
marker protein Rab7 and lysosomalmembrane protein LAMP-2 [56,57].
The molecular mechanisms governing autophagosome maturation
remain unclear, but recent studies have identiﬁed new regulators of
autophagosome maturation and degradation such as UVRAG [58],
Rubicon [59,60], presenilin-1 [14], valosin containing protein (VCP)
[61], and syntaxin-5 SNARE complex proteins [62]. UVRAG interacts
with the class C vacuolar protein sorting complex, a key machinery for
endosomal fusion, and enhances Rab7 activity for promoting autopha-
gosome fusion with late endosomes and lysosomes [58]. Interestingly,
interaction of UVRAG with Rubicon negatively regulates autophago-
some maturation [59,60]. On the other hand, inhibition of presenilin-1
[14], VCP [61] or syntaxin-5 SNARE complex [62] impairs lysosomal
degradation of autophagosomes. Knowing how these molecules
function and work together would provide a clearer picture of the
maturation and degradation process.
2.4. Post-translational control of macroautophagy regulators
Regulation of macroautophagy further involves post-translational
modiﬁcations ofmacroautophagy-relatedproteins (Fig. 1). In particular,
phosphorylation often modulates the function of macroautophagy
regulators that are implicated in the initiation of macroautophagy and
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Fig. 1.Molecular regulation of autophagosome formation in mammalian macroautophagy. Macroautophagy begins with the assembly of molecular players at isolation membrane to
initiate autophagosome formation, followed by nucleation and elongation of the membranes. The ULK protein complex comprising ULK1, Atg13, FIP200 and Atg101 dissociates from
mTORC1 and assembles at the isolation membrane to initiate autophagosome formation during cellular stimuli such as starvation. Membrane nucleation involves the formation of
Beclin 1/PI3K complex, coordinated by the interactions between Beclin 1, UVRAG, Atg14, Bcl-2, p150, ambra1, endophilin B1 and Vps34. Elongation of membranes requires Atg3,
Atg4, Atg7, Atg10, and an Atg5–Atg12–Atg16L1 complex to conjugate PE to LC3, leading to the translocation of LC3 from cytoplasm to themembrane of the forming autophagosomes.
Phosphorylation and acetylation of macroautophagy machinery proteins provide additional control over autophagosome formation.
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autophagy requires ULK1 phosphorylation by adenosine monopho-
sphate-activated protein kinase (AMPK), while ULK1 phosphorylation
by another kinase mTOR, a component of mTORC1, inhibits macro-
autophagy through its regulationofULK1/AMPK interaction [63–65]. On
the other hand, phosphorylation of Bcl-2 by c-Jun N-terminal protein
kinase 1 [66] and that of Beclin-1 by DAPK [50] reduce the inhibitory
binding of Bcl-2 to Beclin 1 to increase autophagosome formation.
Vps34 phosphorylation mediated by cyclin-dependent kinase 1 de-
creases the binding afﬁnity of Vps34 to Beclin 1, thereby reducing
macroautophagy induction [67]. Protein kinase A-dependent phosphor-
ylation of LC3 was also shown to reduce the formation of autophago-
somes [68]. In addition, we have recently demonstrated that
phosphorylation of endophilin B1 by cyclin-dependent kinase 5
(Cdk5), a proline-directed serine/threonine kinase with a predomi-nantly neural-speciﬁc activity, facilitates the interaction of endophilin
B1 with UVRAG and Beclin 1, leading to macroautophagy induction in
neurons [69]. All these ﬁndings underscore the importance of protein
phosphorylation in controlling the initiation of macroautophagy and
autophagosome formation in the cell.
Acetylation of macroautophagy regulators presents another mech-
anism by which macroautophagy is modulated. For example, acetyla-
tion status of several Atg proteins includingAtg5, Atg7, LC3, andAtg12 is
inversely correlated with the cellular level of macroautophagy [70,71]
(Fig. 1). Knockdown of acetyltransferase p300 reduces acetylation of
Atg5, Atg7, LC3 and Atg12 and enhances macroautophagy, while
overexpression of p300 increases acetylation of these Atg proteins and
inhibits macroautophagy [71]. Furthermore, acetylation of Atg5 is
markedly elevated in mice lacking deacetylase Sirtuin-1, which exhibit
macroautophagy-deﬁcit phenotypes such as accumulation of protein
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knockout mice [72]. Regulating the acetylation status of macroauto-
phagy-related proteins thus modulates the level of macroautophagy in
the cell. In addition, proteolytic processing of macroautophagy proteins
has emerged as another regulatory mechanism of macroautophagy
since both cleavage of Beclin 1 by caspase [73] and that of Atg5 by
calpain [74] reduces macroautophagy.
Recent studies revealed that post-translational modiﬁcations of
macroautophagy regulators also take part in conferring selectivity in
the macroautophagy of certain cytoplasmic content such as protein
aggregates, organelles, and intracellular pathogens. In particular, ubiqui-
tination has emerged as an importantmechanism formediating selective
degradation of protein aggregates through macroautophagy [75–78].
Ubiquitinated protein aggregates are recognized by p62 and NBR1 that
deliver the aggregates to autophagosomal membranes [79–81]. Autop-
hagy-linked FYVE protein (Alfy), an Atg5-interacting protein, is further
recruited to p62-positive protein aggregates and facilitates their
macroautophagic degradation through scaffolding the interaction be-
tween the aggregates and Atg5 [82,83]. To selectively target damaged
mitochondria for macroautophagic degradation, a process known as
mitophagy, ubiquitin E3 ligase Parkin is translocated from cytoplasm to
the damaged mitochondria through the action of PINK1 [10–12,84]. It
was further reported that Parkin ubiquitinates themitochondrial protein
Voltage-dependent anion channel 1 (VDAC1), which recruits p62 and
directs the damaged mitochondria into autophagosomal membranes for
subsequentmacroautophagic degradation [12]. Nonetheless, it should be
noted that another research group failed to detect the involvement of
VDAC1andp62 in this process [85]. Another intriguingobservation is that
Parkin promotesmitophagy in PINK1-deﬁcient cells [86], suggesting that
Parkin may also trigger mitophagy in a PINK1-independent manner.
Additional proteins such as Nix [87,88] are required for mitophagy of
damaged mitochondria, but the mechanisms involved remain unclear.
Ubiquitination also facilitates the macroautophagic degradation of
intracellular pathogens. For example, intracellular bacteria coated with
ubiquitin are recognized by the ubiquitin-binding protein NDP52 and are
then delivered for macroautophagic degradation, a process called
xenophagy [89]. These ﬁndings collectively underscore the importance
of ubiquitination in selecting substrates for macroautophagic degrada-
tion. Another post-translational modiﬁcation demonstrated to facilitate
selective targeting of cargo for macroautophagy is acetylation. Upon
acetylation, the aggregation-prone mutant huntingtin proteins are
delivered to autophagosomes, resulting in increased clearance through
macroautophagy [90]. Precise regulatory mechanisms are therefore
present in the cell to facilitate selective degradation of cytoplasmic
contents through macroautophagy to prevent any undesired removal.
2.5. Subtypes of macroautophagy
Subtypes of macroautophagy that are independent of Atg5 and Atg7
[91]orBeclin 1 [92–95]havebeen reported. The regulationofAtg5/Atg7-
independent macroautophagy involves ULK1, Beclin 1, and an endo-
some-Golgi transport protein Rab9 [91], whereas Beclin 1-independent
macroautophagy has been demonstrated to bypass the requirement for
PI3K [96]. Further investigations are required to understand the
molecular details of these subtypes of macroautophagy. Interestingly,
recent evidence suggests that “basal” and “stress-induced/pathological”
macroautophagy may emerge as two subtypes of macroautophagy that
possibly involve distinct sets of macroautophagic machinery. For
example, in rat neurons, endophilin B1 phosphorylation by Cdk5 is
required for macroautophagy and neuronal death induced by several
stress- or death-inducing stimuli, but is dispensable for basal macro-
autophagy [69]. Furthermore, an engulfment factorDraper functions as a
regulator of macroautophagy during cell death, but is not involved in
starvation-inducedmacroautophagy that are associatedwith survival in
Drosophila cells [97]. These ﬁndings suggest that “stress-induced/
pathological” macroautophagy may recruit a unique set of macroauto-phagy regulators. The possible presence of distinct macroautophagic
machineries for “basal” and “stress-induced/pathological” macroauto-
phagy raises the possibility that they may indeed be two subtypes of
macroautophagy. It will be important to further dissect the signaling
pathways that are implicated in determining the subtypes of macro-
autophagy activated in the cells.
3. Deregulation of macroautophagy in diseases
Macroautophagy is crucial for cell survival in stressful conditions and
for maintenance of cellular homeostasis [98]. Increasing evidence
indicates that macroautophagy machineries are deregulated in diverse
human diseases, including neurodegenerative disorders, cancers and
inﬂammatory disorders [3,7,8,99]. Notably, macroautophagy is deregu-
lated at distinct steps including autophagosome nucleation, maturation
and degradation in each of these diseases.
3.1. Neurodegenerative disorders
Neurodegenerative disorders including Alzheimer's disease (AD),
Parkinson's disease (PD), Huntington's disease (HD) and various
spinocerebellar ataxias are characterized by pathologies including
neuronal dysfunction, neuronal death and accumulation of disease
proteins [100,101]. Excessive activation of macroautophagy or defects
in autophagosome maturation and degradation has been described in
these disorders and is tightly associated with disease pathology.
Mutations in presenilin-1 that cause early-onset AD have been
associated with defective lysosomal degradation of autophagosomes
[14]. Moreover, impaired lysosomal degradation selectively disrupts
axonal transport of autophagosomes, causing their accumulationwithin
the dystrophic axons [102]. Since autophagosomes are enriched with
amyloid-beta (Aβ) precursor protein and its processing enzymes for
generating toxic Aβ [103], the accumulation of autophagosomes caused
by impaired lysosomal degradation in ADmay represent a source of Aβ
that contributes to neurodegeneration [103]. Supporting this idea,
autophagosome accumulation is detected in the brain of AD patients
[104]. Genetically ameliorating the impaired macroautophagic and
lysosomal degradation in anADmousemodel reduces Aβ accumulation
andmemory deﬁcits [105]. Nevertheless, decreased Beclin 1 expression
is also detected in AD brains, whereas Beclin 1-deﬁcient mice display
decreased macroautophagy but increased neurodegeneration [106].
Further studies will elucidate the association betweenmacroautophagy
deregulation and AD pathogenesis.
Multiplication of alpha-synuclein (α-syn) gene, and thus its
increased expression, is one of the genetic causes of PD. While α-syn
overexpression reduces the level of Atg7 and impairs macroautophagy
[107,108], viral transfer of Atg7 or Beclin 1 gene, or infusion of
rapamycin, increases macroautophagy and ameliorates neurodegener-
ative phenotypes in mice overexpressing α-syn [107,109]. Conversely,
macroautophagy is induced in neurons expressing PD-associated A53T
mutantα-synproteins [110–112]. Genetic knockdownofAtg5, Atg12or
endophilin B1 inhibits neuronal death in A53T α-syn-expressing
neurons, indicating that macroautophagy is involved in induced
neuronal loss in this disease context [69,110]. Furthermore, PD-
associated mutations in Parkin [10–12,113] and PINK1 [13] interfere
with their functions in promotingmitophagy of damagedmitochondria,
the level of which inﬂuences cell survival [86]. The extent of
macroautophagy is also altered in cells deﬁcient in Leucine-rich repeat
kinase 2 (LRRK2) [114,115], with the PD-linked mutation in LRRK2
increasing autophagosome level [116]. Further studies will deﬁne how
LRRK2 and its mutations contribute to neurodegeneration through
deregulating macroautophagy.
Macroautophagy degrades expanded polyglutamine-containing dis-
ease proteins found in HD and spinocerebellar ataxias, as well as PD-
associated A53Tα-syn proteins [117,118]. It was recently revealed that in
model of HD, engulfment of cytosolic content by autophagosomes is
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The disruption of axonal transport in HD [119,120] and the reduced level
of lysosomes in PD models [121,122] may also contribute to inefﬁcient
degradation of autophagosomes in neurons. Although it remains
controversial as to whether the accumulation of disease proteins
mediates neuronal toxicity or serve a protective function [123], clearance
of disease proteins found in HD and spinocerebellar ataxias by
pharmacological activation of macroautophagy is often accompanied by
an alleviation of neurodegenerative phenotypes [30,124,125], suggesting
a protective role of macroautophagy in pathogenesis of HD and
spinocerebellar ataxias.
3.2. Cancers
A number of macroautophagy-related genes have been reported to
be mutated or downregulated in cancers. Beclin 1 is mono-allelically
deleted in human breast, ovarian and prostate cancers, and the
expression of Beclin 1 is reduced in cancers, including those in breast,
ovary and the brain [126,127]. In addition, mice lacking Beclin 1 have
a high incidence of spontaneous tumor formation [128,129], while
gene transfer of Beclin 1 inhibits the tumorigenicity of breast cancer
cells in mice and the growth of breast cancer cell lines [126].
Restoration of Beclin 1 expression also inhibits the growth of colon
cancer cells [130]. These ﬁndings collectively demonstrate that
decreased expression of Beclin 1 leads to tumorigenesis.
Similar to mice deﬁcient in Beclin 1, endophilin B1 null mice also
form spontaneous tumors at a high frequency, indicating a tumor-
suppressive function of endophilin B1 [47]. Mutation in endophilin B1
is rare in cancers, with only one somatic mutation detected in lung
carcinoma [131]. Nonetheless, decreased expression of endophilin B1
is common in various cancers including colorectal adenocarcinoma
and gastric cancers, as well as in subsets of urinary bladder,
gallbladder and prostate cancers [132–135]. UVRAG is another
macroautophagy regulator that suppresses the proliferation of
human colon cancer cells [40]. Mutations in UVRAG are frequently
detected in colon cancers [136], and are also observed in gastric
cancers [137].
It is hypothesized that the tumor-suppressive functions of Beclin 1,
endophilin B1 and UVRAG, the three components of the Beclin 1/PI3K
complex, are attributed to their roles in autophagosome nucleation,
and/or other functions such as the control of cell division [138].
Nevertheless, it was reported that colon cancer-associated mutations
in UVRAG do not affect its function in macroautophagy [139].
Mutations in other macroautophagy genes such as Atg5 are also
detected in gastric and colorectal cancers [140]. Further studies will
deﬁne whether these mutations contribute to tumorigenesis through
affecting macroautophagy.
3.3. Inﬂammatory disorders
Deregulation of macroautophagy occurs in several inﬂammatory
disorders. In cystic ﬁbrosis, a chronic inﬂammatory disorder caused by
mutations in the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) gene, mutations in CFTR result in mislocalization of the Beclin
1/PI3K complex and inhibit macroautophagy in lung epithelial cells
[15]. Importantly, restoring the expression of Beclin 1 or the level of
macroautophagy alleviates the cystic ﬁbrosis disease phenotypes [15],
suggesting a detrimental role of deregulated macroautophagy in the
pathogenesis of cystic ﬁbrosis.
Macroautophagy directs intracellular pathogens including bacteria
into autophagosomes for lysosomal degradation. Interestingly, Crohn's
disease, a chronic inﬂammatory disorder of the small intestine, exhibits
impaired bacterial clearance and susceptibility to the disease is
increased in patients with mutations in three marcoautophagy-related
genes NOD2, Atg16L1 and IRGM [99]. Crohn's disease-associated NOD2
risk variants-expressing cells show defects in macroautophagy induc-tion [141] and aberrant engulfment of bacteria into autophagosomes
[142], supporting a link between macroautophagic deregulation and
Crohn's disease. Conversely, despite the reported functions of Atg16L1
[35] and IRGM [143] in macroautophagy regulation, it remains to be
clariﬁedwhether the Crohn's disease-associated risk variants contribute
to bacterial clearance and disease pathology through altering their
functions in macroautophagy regulation [99].
3.4. Macroautophagy deregulation in other diseases
Deregulated macroautophagy has been reported in diseases such
as inclusion body myopathy associated with Paget's disease of bone
and frontotemporal dementia (IBMPFD), centronuclear myopathy
and Pompe disease. Notably, IBMPFD-associated mutations in VCP
impair its function in autophagosome maturation and degradation
[61,144], while a mutation in Jumpy found in centronuclear myopathy
also disrupts its regulation of macroautophagy [37]. In addition,
impaired autophagosome maturation is implicated in Pompe disease
pathology [145], with the disease pathology alleviated in macro-
autophagy-deﬁcient mice following therapy [146]. It would be
interesting to understand how macroautophagy contributes to the
pathologies of these diseases.
4. Conclusions
It is evident that deregulation of macroautophagy occurs in various
diseases, and disease-associated pathologies can be alleviated by
modulating the level of macroautophagy. Nonetheless, each disease
involves deregulation of macroautophagy at distinct steps such as
autophagosome nucleation, maturation and degradation. Substantial
progress has been made in the past decade to decipher the molecular
mechanisms governing macroautophagy, and we are beginning to
understand how macroautophagy is selectively and differentially
regulated under various physiological and disease conditions. Eluci-
dating the molecular mechanisms underlying the precise regulation
of macroautophagy will shed light on novel therapeutic targets or
strategies for these diseases.
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